These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 24357671

  • 1. Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.
    Scarpellini A, Huang L, Burhan I, Schroeder N, Funck M, Johnson TS, Verderio EA.
    J Am Soc Nephrol; 2014 May; 25(5):1013-27. PubMed ID: 24357671
    [Abstract] [Full Text] [Related]

  • 2. Proteomic Profiling Reveals the Transglutaminase-2 Externalization Pathway in Kidneys after Unilateral Ureteric Obstruction.
    Furini G, Schroeder N, Huang L, Boocock D, Scarpellini A, Coveney C, Tonoli E, Ramaswamy R, Ball G, Verderio C, Johnson TS, Verderio EAM.
    J Am Soc Nephrol; 2018 Mar; 29(3):880-905. PubMed ID: 29382685
    [Abstract] [Full Text] [Related]

  • 3. Insights into the heparan sulphate-dependent externalisation of transglutaminase-2 (TG2) in glucose-stimulated proximal-like tubular epithelial cells.
    Furini G, Burhan I, Huang L, Savoca MP, Atobatele A, Johnson T, Verderio EAM.
    Anal Biochem; 2020 Aug 15; 603():113628. PubMed ID: 32074489
    [Abstract] [Full Text] [Related]

  • 4. Interplay between transglutaminases and heparan sulphate in progressive renal scarring.
    Burhan I, Furini G, Lortat-Jacob H, Atobatele AG, Scarpellini A, Schroeder N, Atkinson J, Maamra M, Nutter FH, Watson P, Vinciguerra M, Johnson TS, Verderio EA.
    Sci Rep; 2016 Oct 03; 6():31343. PubMed ID: 27694984
    [Abstract] [Full Text] [Related]

  • 5. The effect of TG2-inhibitory monoclonal antibody zampilimab on tissue fibrosis in human in vitro and primate in vivo models of chronic kidney disease.
    Huang L, Bon H, Maamra M, Holmes T, Atkinson J, Cain K, Kennedy J, Kettleborough C, Matthews D, Twomey B, Ni J, Song Z, Watson PF, Johnson TS.
    PLoS One; 2024 Oct 03; 19(5):e0298864. PubMed ID: 38753630
    [Abstract] [Full Text] [Related]

  • 6. Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.
    Scarpellini A, Germack R, Lortat-Jacob H, Muramatsu T, Billett E, Johnson T, Verderio EA.
    J Biol Chem; 2009 Jul 03; 284(27):18411-23. PubMed ID: 19398782
    [Abstract] [Full Text] [Related]

  • 7. Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration.
    Shweke N, Boulos N, Jouanneau C, Vandermeersch S, Melino G, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ.
    Am J Pathol; 2008 Sep 03; 173(3):631-42. PubMed ID: 18688035
    [Abstract] [Full Text] [Related]

  • 8. Feline chronic kidney disease is associated with upregulation of transglutaminase 2: a collagen cross-linking enzyme.
    Sánchez-Lara AC, Elliott J, Syme HM, Brown CA, Haylor JL.
    Vet Pathol; 2015 May 03; 52(3):513-23. PubMed ID: 25047228
    [Abstract] [Full Text] [Related]

  • 9. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.
    Wang Z, Collighan RJ, Gross SR, Danen EH, Orend G, Telci D, Griffin M.
    J Biol Chem; 2010 Dec 17; 285(51):40212-29. PubMed ID: 20929862
    [Abstract] [Full Text] [Related]

  • 10. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
    Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A.
    J Clin Invest; 2003 Nov 17; 112(10):1486-94. PubMed ID: 14617750
    [Abstract] [Full Text] [Related]

  • 11. Tissue-resident natural killer cells exacerbate tubulointerstitial fibrosis by activating transglutaminase 2 and syndecan-4 in a model of aristolochic acid-induced nephropathy.
    Wee YM, Go H, Choi MY, Jung HR, Cho YM, Kim YH, Han DJ, Shin S.
    BMB Rep; 2019 Sep 17; 52(9):554-559. PubMed ID: 31072444
    [Abstract] [Full Text] [Related]

  • 12. Spotlight on the Transglutaminase 2-Heparan Sulfate Interaction.
    Furini G, Verderio EAM.
    Med Sci (Basel); 2019 Jan 04; 7(1):. PubMed ID: 30621228
    [Abstract] [Full Text] [Related]

  • 13. Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells.
    Nadella V, Wang Z, Johnson TS, Griffin M, Devitt A.
    Biochim Biophys Acta; 2015 Jan 04; 1853(1):201-12. PubMed ID: 25449226
    [Abstract] [Full Text] [Related]

  • 14. Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.
    Badarau E, Wang Z, Rathbone DL, Costanzi A, Thibault T, Murdoch CE, El Alaoui S, Bartkeviciute M, Griffin M.
    Chem Biol; 2015 Oct 22; 22(10):1347-61. PubMed ID: 26456735
    [Abstract] [Full Text] [Related]

  • 15. Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney.
    Lin CH, Chen J, Zhang Z, Johnson GV, Cooper AJ, Feola J, Bank A, Shein J, Ruotsalainen HJ, Pihlajaniemi TA, Goligorsky MS.
    Kidney Int; 2016 Jun 22; 89(6):1281-92. PubMed ID: 27165830
    [Abstract] [Full Text] [Related]

  • 16. Transglutaminase 2 knockout mice are protected from bleomycin-induced lung fibrosis with preserved lung function and reduced metabolic derangements.
    Freeberg MAT, Thatcher TH, Camus SV, Huang L, Atkinson J, Narrow W, Haak J, Dylag AM, Cowart LA, Johnson TS, Sime PJ.
    Physiol Rep; 2024 Jun 22; 12(12):e16012. PubMed ID: 38959068
    [Abstract] [Full Text] [Related]

  • 17. Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis.
    Tatsukawa H, Otsu R, Tani Y, Wakita R, Hitomi K.
    Sci Rep; 2018 May 09; 8(1):7306. PubMed ID: 29743665
    [Abstract] [Full Text] [Related]

  • 18. Transglutaminase 2 and its role in pulmonary fibrosis.
    Olsen KC, Sapinoro RE, Kottmann RM, Kulkarni AA, Iismaa SE, Johnson GV, Thatcher TH, Phipps RP, Sime PJ.
    Am J Respir Crit Care Med; 2011 Sep 15; 184(6):699-707. PubMed ID: 21700912
    [Abstract] [Full Text] [Related]

  • 19. Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix.
    Lortat-Jacob H, Burhan I, Scarpellini A, Thomas A, Imberty A, Vivès RR, Johnson T, Gutierrez A, Verderio EA.
    J Biol Chem; 2012 May 25; 287(22):18005-17. PubMed ID: 22442151
    [Abstract] [Full Text] [Related]

  • 20. Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor.
    Wang Z, Stuckey DJ, Murdoch CE, Camelliti P, Lip GYH, Griffin M.
    Cell Death Dis; 2018 Apr 27; 9(6):613. PubMed ID: 29795262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.